Stockscreener 앱 받기
2.07
0.00%
0.00
시간 외 거래:
2.07
전일 마감가:
$2.07
열려 있는:
$2.08
하루 거래량:
267.13K
Relative Volume:
1.01
시가총액:
$35.86M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.48%
1개월 성능:
+17.61%
6개월 성능:
-46.92%
1년 성능:
-36.11%
1일 변동 폭
$2.07
$2.08
1주일 범위
$2.07
$2.09
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.07 | 35.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Citadel Group discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.55% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.73% stake in Mural Oncology - Investing.com
Trium Capital discloses 10.55% stake in Mural Oncology - Investing.com
Bull Run: Can LDTCW keep up with sector leadersVolume Spike & Real-Time Volume Trigger Notifications - خودرو بانک
Resistance Check: Why is RMBI stock going down2025 Growth vs Value & Comprehensive Market Scan Insights - خودرو بانک
Market Outlook: Can Integra Resources Corp reach all time highs this yearQuarterly Growth Report & Growth Focused Investment Plans - خودرو بانک
Fundamentals Check: Is Mural Oncology plc a defensive stockQuarterly Performance Summary & Weekly Stock Performance Updates - خودرو بانک
Sentiment Recap: Is Mural Oncology plc stock influenced by commodity prices2025 Stock Rankings & Safe Entry Point Identification - خودرو بانک
Big Picture: What dividend growth rate does Mural Oncology plc offer2025 Geopolitical Influence & AI Driven Price Forecasts - خودرو بانک
Citadel Group discloses 1.75% stake in Mural Oncology - Investing.com India
Dow Update: Can OILU reach all time highs this yearCPI Data & Low Risk High Win Rate Picks - خودرو بانک
Bull Bear: Is Mural Oncology plc a defensive stock2025 Macro Impact & AI Forecast Swing Trade Picks - خودرو بانک
Gains Recap: Can Mural Oncology plc benefit from deglobalizationJuly 2025 Setups & Low Risk Investment Opportunities - خودرو بانک
Citadel Group discloses 1.76% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.76% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - MarketScreener
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders - GlobeNewswire Inc.
Citadel discloses 1.73% stake in Mural Oncology - Investing.com
Citadel discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology By Investing.com - Investing.com Australia
BlackRock discloses 1.61% stake in Mural Oncology By Investing.com - Investing.com Canada
Is Mural Oncology plc stock a good dividend stockWeekly Trend Report & AI Driven Price Predictions - Lancaster City Council
BlackRock discloses 1.61% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Recovery Path — Analyst Breakdown2025 Macro Impact & Consistent Return Investment Signals - beatles.ru
Is Mural Oncology plc showing insider buyingWeekly Market Report & Daily Profit Maximizing Tips - beatles.ru
Pattern Scan Adds Mural Oncology plc to Watchlist2025 Top Gainers & Verified Momentum Stock Ideas - beatles.ru
Is Mural Oncology plc’s ROE strong enoughJuly 2025 Gainers & Daily Momentum Trading Reports - 강소기업뉴스
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com Nigeria
Visual analytics tools that track Mural Oncology plc performanceWeekly Risk Report & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Mural Oncology plc2025 Market WrapUp & Safe Capital Preservation Plans - Newser
What to expect from Mural Oncology plc in the next 30 daysGold Moves & Fast Exit and Entry Strategy Plans - Newser
Sector ETF performance correlation with Mural Oncology plcPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Heatmap analysis for Mural Oncology plc and competitorsQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Is Mural Oncology plc vulnerable to short sellersRisk Management & Weekly Hot Stock Watchlists - خودرو بانک
Citadel Group discloses 1.68% stake in Mural Oncology By Investing.com - Investing.com Canada
Will Mural Oncology plc benefit from rising consumer demand2025 Major Catalysts & Advanced Swing Trade Entry Plans - خودرو بانک
Can Mural Oncology plc be the next market leaderEarnings Trend Report & Weekly Stock Performance Updates - خودرو بانک
Is it time to cut losses on Mural Oncology plc2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Is Mural Oncology plc reversing from oversold territory2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
What institutional flow reveals about Mural Oncology plc2025 Year in Review & Smart Allocation Stock Reports - Newser
Is Mural Oncology plc exposed to currency risksGap Up & Low Risk Profit Maximizing Plans - خودرو بانک
BlackRock discloses 1.62% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.65% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.68% stake in Mural Oncology - Investing.com India
Boston M&A in August Mural Oncology, UWill and scPharmaceuticals - The Business Journals
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Mural Oncology Plc 주식 (MURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
0.77%
1.53%
자본화:
|
볼륨(24시간):